Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study.
about
Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatmentAn update on pelvic inflammatory diseaseReduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade.Epidemiology, pathogenesis and treatment of pelvic inflammatory disease.Analysis of Factors Driving Incident and Ascending Infection and the Role of Serum Antibody in Chlamydia trachomatis Genital Tract Infection.Risk factors associated with pelvic inflammatory disease
P2860
Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2001
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hormonal and barrier contracep ...... Clinical Health (PEACH) study.
@en
Hormonal and barrier contracep ...... Evaluation and Clinical Health
@nl
type
label
Hormonal and barrier contracep ...... Clinical Health (PEACH) study.
@en
Hormonal and barrier contracep ...... Evaluation and Clinical Health
@nl
prefLabel
Hormonal and barrier contracep ...... Clinical Health (PEACH) study.
@en
Hormonal and barrier contracep ...... Evaluation and Clinical Health
@nl
P2093
P356
P1476
Hormonal and barrier contracep ...... Clinical Health (PEACH) study.
@en
P2093
A Amortegui
PID Evaluation and Clinical Health (PEACH) Study Investigators
R L Holley
P304
P356
10.1067/MOB.2001.115114
P407
P577
2001-07-01T00:00:00Z